What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Gian Life Care Limited IPO?

Gian Life Care Limited IPO has received a total subscription of 0.00 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Gian Life Care Limited

ListedSME

Healthcare / Diagnostic Services · BSE

Gian Life Care Limited, founded in 2018 and based in Kanpur, Uttar Pradesh, is a diagnostic and healthcare service provider offering a wide range of tests and health services focused on diagnosis, prevention, and wellness for individuals as well as hospitals and corporate clients. The company provides over 1,344 diagnostic tests covering areas such as biochemistry, clinical pathology, hematology, histopathology, microbiology, molecular biology, immunoassay, cytogenetics, cytology, coagulation, and radiology. Gian Life Care operates as an NABL accredited and ISO 9001:2015 certified organization and is supported by a team of 59 full-time employees.

Price Band

₹22

Issue Size

₹3.00 Cr

Lot Size

6000 shares

GMP

—

Est. Listing

₹22

at current GMP

Subscribed

—

Open

31 Dec 2019

3 Jan 2020

Allotment

8 Jan 2020

Refund

9 Jan 2020

Demat Credit

10 Jan 2020

Listing

13 Jan 2020

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

0.00x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 0.00x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	681,818	—	0.00x
Non-Institutional (NII / HNI)	204,545	—	0.00x
Retail Individual (RII)	477,273	—	0.00x
Total	1,363,636	0	0.00x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.00x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	80	80	1.00x
HNIs (10L +)	1	1	1.00x
HNIs (2-10L)	2	2	1.00x
Total Applications	83	83	1.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Gian Life Care Limited Public Issue & Market Profile

Gian Life Care Limited is bringing an initial public offering (IPO) in the Healthcare / Diagnostic Services sector with an aggregate issue size of ₹3 Crores. The shares are offered at a price band of ₹22 to ₹22 per equity share on BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2020-01-03, the basis of allotment is scheduled to be finalized on 2020-01-08. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Cameo Corporate Services Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Gian Life Care Limited IPO GMP today?

Currently, Gian Life Care Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹22 to ₹22 per equity share.

What is the expected profit per lot for Gian Life Care Limited IPO?

The retail lot size is 6000 shares requiring a minimum application amount of ₹1,32,000. Expected listing price is ₹22 per equity share.

What is the issue size and price band for Gian Life Care Limited IPO?

The Gian Life Care Limited IPO aggregate issue size is ₹3 Crores with an equity price band set at ₹22 to ₹22 per equity share. The retail lot size is 6000 shares requiring a minimum capital outlay of approx. ₹1,32,000.

How can I check Gian Life Care Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Gian Life Care Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Cameo Corporate Services Limited) and the BSE status verification website on or around 2020-01-08. Investors can verify status using PAN card or application number.

When is the listing date for Gian Life Care Limited IPO?

Gian Life Care Limited shares are scheduled to list on BSE on 2020-01-13.